PACTR201807135085505尚未招募1 期
SAVING BRAINS FROM MALNUTRITION: IMPLEMENTATION OF EVIDENCE-BASED NUTRITIONAL SUPPLEMENTATION AND PSYCHOSOCIAL STIMULATION PROGRAMME FOR PREGNANT AND LACTATING WOMEN AND THEIR INFANTS POST WEANING, TO IMPROVE COGNITION AND BEHAVIOURAL REGULATION TO DELIVER BETTER SOCIAL AND ECONOMIC PROSPECTS LATER IN LIFE
utriset0 个研究点目标入组 180 人开始时间: 2018年7月10日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 180
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 1 Month(s) 至 23 Month(s)（—）
- 性别
- All
入选标准
- •infant between 6 -18 months,
- •lactating mothers
排除标准
- •infants less than 6 months,
- •an unwell pregnant woman,
- •persons allergic to peanut
研究者
相似试验
进行中（未招募）
不适用
A double-blind randomised placebo controlled feeding study to establish the effect of a probiotic strain on the course of Clostridium difficile carriage in humans.Clostridium difficile infectionEUCTR2006-000379-14-IEAlimentary Health Ltd100
进行中（未招募）
1 期
A Double-Blind, Placebo Controlled, Half-Head Design, CPO Solution Dose Ranging-Finding Study in Patients with Seborrhoeic Dermatitis of the Scalp - Dose Range-Finding StudySeborrhoeic dermatitisMedDRA version: 8.0Level: LLTClassification code 10039793EUCTR2005-001371-35-GBStiefel Laboratories Maidenhead Ltd (commonly known as Stiefel Laboratories International Division)60
已完成
不适用
A pilot study to investigate the effects of short course oral corticosteroid therapy in early dengue infection in Vietnamese patientsInfections and InfestationsDengue fever [classical dengue]Dengue feverISRCTN39575233niversity of Oxford (UK)225
进行中（未招募）
不适用
A randomised, double blind, placebo-controlled, double dummy, 4-way cross-over, dose ascending study to assess the safety, tolerability, pharmacodynamics and pharmacokinetics of single inhaled doses of GSK573719 (250, 500 and 1000µg) and tiotropium bromide (18µg) via DPI in COPD patients.Chronic Obstructive Pumonary Disease (COPD)MedDRA version: 9.1Level: LLTClassification code 10010952Term: COPDEUCTR2007-000187-25-DEGlaxoSmithKline Research & Development Ltd
进行中（未招募）
不适用
A randomised, placebo-controlled, double-blind, double-dummy, crossover study to assess the onset of action of two inhalations of Symbicort 160/4.5µg compared with two inhalations of Seretide 25/250µg, two inhalations of Ventoline 100µg, and placebo, delivered by pressurised metered dose inhalers, in patients with chronic obstructive pulmonary disease (COPD). - OSSCARThis is an application for a phase III study to be conducted in COPD patients.Classification code 10010952EUCTR2004-001724-20-HUAstraZeneca AB